Diametric Capital, LP Dexcom Inc Transaction History

Diametric Capital, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$114.22 - $140.1 $399,427 - $489,929	3,497 New	3,497 $485,000
Q3 2023 Nov 14, 2023	BUY	$86.06 - $137.93 $1.7 Million - $2.72 Million	19,708 New	19,708 $1.84 Million
Q1 2023 May 11, 2023	SELL	$104.0 - $122.92 $226,928 - $268,211	-2,182 Reduced 18.82%	9,409 $1.09 Million
Q4 2022 Mar 29, 2023	BUY	$84.98 - $122.67 $985,003 - $1.42 Million	11,591 New	11,591 $1.31 Million
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $1.39 Million - $2.71 Million	20,397 Added 306.72%	27,047 $2.02 Million
Q1 2022 May 16, 2022	BUY	$94.08 - $130.2 $625,632 - $865,829	6,650 New	6,650 $3.4 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Diametric Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Diametric Capital, LP with notifications on news.